|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Potential of albiglutide,a long-acting GLP-1 receptor agonist,in T2D:a randomized controlled trial exploring w eekly,biw eekly,and monthly dosing显示文摘 | Rosenstock J Reusch J Bush M | 2009 | Diabetes Care2009，32，： | 1 |
| 2 | Anti-CD3 x anti-epidermalgrowth factor receptor (EGFR)bispecific antibody redirects T-cellcytolytic activity to EGFR-positive cancers in vitro and in an animalmodel显示文摘 | Reusch U Sundaram M Davol P A | 2006 | Clin Cancer Res2006，12，： | 1 |
| 3 | Potential of albiglutide,along-acting GLP-1 receptor agonist,in type 2 diabetes:a random-ized controlled trial exploring weekly,biweekly,and monthly dosing显示文摘 | Rosenstock J Reusch J Bush M | 2009 | Diabetes Care2009，32，10： | 1 |
| 4 | Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glyco- sylation profiles-Part 2 : Mass spectrometric methods 显示文摘 | REUSCH D HABERGER M FALCK D | 2015 | MAbs2015，7，4： | 1 |
| 5 | Anti-CD3x anti-epiderm- al growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model显示文摘 | Reusch U Sundaram M Davol P A | 2006 | Clinical cancer research2006，12，1： | 1 |
| 6 | Potential of albiglutide,a long-acting GLP-1 receptor agonist,in type 2 diabetes:a randomized controlled trial exploring w eekly,biw eekly,and monthly dosing显示文摘 | Rosenstock J Reusch J Bush M | 2009 | Diabetes Care2009，32，10： | 1 |
| 7 | Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes a randomized controlled trial exploring weekly, biweekly, and monthly dosing显示文摘 | ROSENSTOCK J REUSCH J BUSH M | 2009 | Diab Care2009，32，10： | 1 |
| 8 | Inanspruchnahme der Grippeschutzimpfung bei Patienten mit mittelschwerer oder schwerer Psoriasis 显示文摘 | Radtke MA Rustenbach SJ Reusch M | 2013 | J Dtsch Dermatol Ges2013，11，9： | 1 |
| 9 | Female sticklebacks count alleles in a strategy of sexual selection explaining MHC polymorphism显示文摘 | Reusch T B H H berli M A Aeschlimann P B | 2001 | Nature2001，414，： | 1 |
| 10 | Potential of albiglutide,a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing 显示文摘 | Rosenstoek J Reusch J Bush M | 2009 | Diab Care2009，32，： | 1 |
| 11 | An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells显示文摘 | Siemeister G Schimer M Reusch P | 1998 | Proc Natl Acad Sci USA1998，95，8： | 1 |
| 12 | Recent duplication and inter-locus gene conversion in major histocompatibility class Ⅱ genes in a teleost, the three-spined stickleback显示文摘 | Reusch T B Schaschl H Wegner K M | 2004 | Immunogenetics2004，56，6： | 1 |
| 13 | Local genetic structure in a clonal dioecious Angiosperm显示文摘 | Ruggiero M V Reusch T B H Procaccini G | 2005 | Molecular Ecolo- gy2005，14，： | 1 |
| 14 | 显示文摘 | Brock C Schaefer M Reusch HP | 2003 | Cell Biol2003，160，： | 1 |
| 15 | Is asexual reproduction more important at geographical limits? A genetic study of the seagrass Zostera marina in the Ria Formosa, Portugal 显示文摘 | BELIJNGHAM M R REUSCH T B H ALBERTO F | 2003 | Mar Ecol-Prog Ser2003，265，： | 1 |
| 16 | Skeletal muscledeoxygenation after the onset of moderate exercise suggests slowedmicrovascular blood flow kinetics in type 2 diabetes 显示文摘 | Bauer TA Reusch JE Levi M | 2007 | Diabetes Care2007，30，11： | 1 |
| 17 | Measurement of capillary blood glucose concentrations by pet owners:a new tool in the management of diabetes mellitus显示文摘 | Casella M Wess G Reusch C E | 2002 | J Am Anim Hosp Assoc2002，38，3： | 1 |
| 18 | Potential of albiglutide,a long-acting GLP-1 receptor agonist,in type 2 diabetes:a randomized controlled trial exploring weekly,biweekly,and monthly dosing显示文摘 | Rosenstock J Reusch J Bush M | 2009 | Diabetes Care2009，32，10： | 1 |
| 19 | Potential of albiglutide, a long-acting GI,P- 1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing显示文摘 | ROSENSTOCK J REUSCH J BUSH M | 2009 | Diabetes Care2009，32，10： | 1 |
| 20 | Two independent mechanisms essential for tumor angiogenesis: Inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway 显示文摘 | Schirner M Weindel K Reusch P Menrad A Marme D Martiny-Baron G | 1999 | Cancer Res1999，59，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员